WO2004087088A1 - Oral composition comprising micron-sized lanthanide metal oxide - Google Patents
Oral composition comprising micron-sized lanthanide metal oxide Download PDFInfo
- Publication number
- WO2004087088A1 WO2004087088A1 PCT/EP2004/003234 EP2004003234W WO2004087088A1 WO 2004087088 A1 WO2004087088 A1 WO 2004087088A1 EP 2004003234 W EP2004003234 W EP 2004003234W WO 2004087088 A1 WO2004087088 A1 WO 2004087088A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oral composition
- metal oxide
- abrasive
- lanthanide metal
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Definitions
- the present invention relates to an oral care composition comprising an improved abrasive system.
- US 5 718 885 discloses the use of particles selected from compounds comprising metals from groups IB, 11A, IIB IIIA, 11IB, IVB, VA, VIA, VIB, VIIB and VIIIB of the periodic table including the Lanthanides in an oral care composition for treating dentinal hypersensitivity. More preferably, the metals are selected from Y, Ce, AL and Zr, most preferably the metal is either Al or Zr.
- the compounds are present in an aqueous colloid and must be capable of having a cationic charge in an aqueous environment.
- they are present as halides, silicates, acetates, oxides and hydroxides. Most preferably they are oxides .
- the compounds have a submicron particle size.
- US 3 573 886 discloses compositions for polishing and comprising rare-earth oxide and woolastonite.
- the rare-earth metal oxides disclosed are used in their naturally occurring state, i.e. comprising a mixture of metals.
- the compositions are used to grind glass.
- GB 2 001 849 discloses acomposition for use in cleaning teeth. Specifically it discloses water-soluble salts of lanthanum and the lanthanides. There is no disclosure of their oxides.
- the present invention provides an oral composition according to claim 1.
- the invention includes the use of an oxide of any of the lanthanide metals and these include La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu. However, the most preferred are lanthanum oxide (La 2 ⁇ 3 ) and cerium oxide (Ce0 2 ) .
- the lanthanide metal oxide has a weight average particle size of from 0.5 to 50 ⁇ m, preferably from 0.6 to lO ⁇ m. Such particle size can be measured on a Malvern Mastersizer® according to standard protocols.
- the lanthanide metal oxide is present in the composition at from 0.01 to 5% by weight of the composition. More preferably from 0.2 to 3% by weight and most preferably from 0.6 to 1.5% by weight of the composition.
- the further abrasive in the oral composition is any abrasive known in the art of oral compositions and includes calcium carbonate, silica, dicalcium phosphates, etc.
- the further abrasive is silica it is preferably present at from 3 to 15% by weight of the composition.
- the further abrasive is calcium carbonate it is preferably present at from 10 to 60% by weight of the composition.
- the invention provides for the use of from 0.01 to 5% by weight of a lanthanide metal oxide as an abrasive in an oral composition.
- compositions for this second aspect of the invention are as described in respect of the first aspect of the invention.
- composition according to the invention comprise further ingredients which are common in the art, such as:
- antimicrobial agents e.g. Triclosan, chlorhexidine, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; bis-guanides, such as chlorhexidine digluconate, hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds, such as 2,2' methylenebis- (4-chloro-6-bromophenol) ; anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin etc.;
- Triclosan chlorhexidine, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride
- bis-guanides such as chlorhexidine digluconate, hexetidine, octenidine, alexidine
- halogenated bisphenolic compounds such as 2,2' methylenebis- (4-chloro-6-
- anti-caries agents such as sodium- and stannous fluoride, aminefluorides, sodium monofluorophosphate, sodium trimeta phosphate and casein;
- plaque buffers such as urea, calcium lactate, calcium glycerophosphate and strontium polyacrylates
- vitamins such as Vitamins A, C and E;
- desensitising agents e.g. potassium citrate, potassium chloride, potassium tartrate, potassium bicarbonate, potassium oxalate, potassium nitrate and strontium salts;
- anti-calculus agents e.g. alkali-metal pyrophosphates, hypophosphite-containing polymers, organic phosphonates and phosphocitrates etc.;
- biomolecules e.g. bacteriocins, antibodies, enzymes, etc.
- flavours e.g. peppermint and spearmint oils
- proteinaceous materials such as collagen
- opacifying agents opacifying agents; colouring agents;
- pharmaceutically acceptable carriers e.g. starch, sucrose, water or water/alcohol systems etc.;
- surfactants such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants
- particulate abrasive materials such as silicas, aluminas, calcium carbonates, dicalciumphosphates, calcium pyrophosphates, hydroxyapatites, trimetaphosphates, insoluble hexametaphosphates and so on, including agglomerated particulate abrasive materials, usually in amounts between 3 and 60% by weight of the oral care composition.
- humectants such as glycerol, sorbitol, propyleneglycol, xylitol, lactitol etc.;
- binders and thickeners such as sodium carboxymethyl- cellulose, xanthan gum, gum arabic etc. as well as synthetic polymers such as polyacrylates and carboxyvinyl polymers such as Carbopol®;
- polymeric compounds which can enhance the delivery of active ingredients such as antimicrobial agents can also be included; buffers and salts to buffer the pH and ionic strength of the oral care composition; and
- bleaching agents such as peroxy compounds e.g. potassium peroxydiphosphate, effervescing systems such as sodium bicarbonate/citric acid systems, colour change systems, and so on.
- Liposomes may also be used to improve delivery or stability of active ingredients.
- the oral compositions may be in any form common in the art, e.g. toothpaste, gel, mousse, aerosol, gum, lozenge, powder, cream, etc. and may also be formulated into systems for use in dual-compartment type dispensers.
- the oral composition according to the invention is made by standard protocols known to the person skilled in the art.
- the RDA is measured according to the protocol described in A Labora tory Method for Assessment of Dentifrice Abrasivity JJ Hefferren Journal Dent Res Vol 55 No 4 563-573 (1976) .
- the PCR is measured according to the protocol described in In vi tro removal of stain with dentifrices GK Stookey, TA Burkhard and BR Schemehorn Journal Dent Res Vol 61 No 11 1236-1239 (1982) .
- Both the cerium oxide and lanthanum oxide are commercially available from Aldrich.
- Cerium (IV) oxide powder cat no: 21,157-5.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Polishing Bodies And Polishing Tools (AREA)
Abstract
Oral composition comprising as abrasive a mixture of a lanthanide metal oxide and a further abrasive, characterised in that the lanthanide metal oxide has a weight average particle size of from 0.5 to 50 ÿm.
Description
ORAL COMPOSITION COMPRISING MICRON-SIZED ANTHANIDE METAL OXIDE
The present invention relates to an oral care composition comprising an improved abrasive system.
US 5 718 885 (Gingold) discloses the use of particles selected from compounds comprising metals from groups IB, 11A, IIB IIIA, 11IB, IVB, VA, VIA, VIB, VIIB and VIIIB of the periodic table including the Lanthanides in an oral care composition for treating dentinal hypersensitivity. More preferably, the metals are selected from Y, Ce, AL and Zr, most preferably the metal is either Al or Zr.
The compounds are present in an aqueous colloid and must be capable of having a cationic charge in an aqueous environment. Suitably they are present as halides, silicates, acetates, oxides and hydroxides. Most preferably they are oxides . The compounds have a submicron particle size.
US 3 573 886 (Goetzinger) discloses compositions for polishing and comprising rare-earth oxide and woolastonite. The rare-earth metal oxides disclosed are used in their naturally occurring state, i.e. comprising a mixture of metals. The compositions are used to grind glass.
DE 28 02 489 (Bayer) discloses cerium salt solutions for use in toothpastes. Cerium chloride is the preferred salt with cerium oxide also being exemplified. There is no disclosure of lanthanum metal oxides with a weight average particle size of from 0.5 to 50 μ .
US 4 165 366 (Mellberg) discloses a prophylactic paste comprising an abrasive at from 40 to 60% by weight of the composition. The preferred abrasive is medium grade pumice, although other abrasives may be used such as zirconium silicate, alumina, cerium oxide, silicon carbide and the like.
GB 2 001 849 (ICI) discloses acomposition for use in cleaning teeth. Specifically it discloses water-soluble salts of lanthanum and the lanthanides. There is no disclosure of their oxides.
Despite all that is available in the prior art there remains the need for improved abrasives suitable for use in toothpastes for everyday use.
Accordingly, the present invention provides an oral composition according to claim 1.
The invention includes the use of an oxide of any of the lanthanide metals and these include La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu. However, the most preferred are lanthanum oxide (La2θ3) and cerium oxide (Ce02) .
Preferably the lanthanide metal oxide has a weight average particle size of from 0.5 to 50μm, preferably from 0.6 to lOμm. Such particle size can be measured on a Malvern Mastersizer® according to standard protocols.
Preferably, the lanthanide metal oxide is present in the composition at from 0.01 to 5% by weight of the composition.
More preferably from 0.2 to 3% by weight and most preferably from 0.6 to 1.5% by weight of the composition.
The further abrasive in the oral composition is any abrasive known in the art of oral compositions and includes calcium carbonate, silica, dicalcium phosphates, etc.
Where the further abrasive is silica it is preferably present at from 3 to 15% by weight of the composition.
Where the further abrasive is calcium carbonate it is preferably present at from 10 to 60% by weight of the composition.
In a second aspect the invention provides for the use of from 0.01 to 5% by weight of a lanthanide metal oxide as an abrasive in an oral composition.
Preferred embodiments of the composition for this second aspect of the invention are as described in respect of the first aspect of the invention.
The oral composition according to the invention comprise further ingredients which are common in the art, such as:
antimicrobial agents, e.g. Triclosan, chlorhexidine, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; bis-guanides, such as chlorhexidine digluconate, hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds, such as 2,2' methylenebis- (4-chloro-6-bromophenol) ;
anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin etc.;
anti-caries agents such as sodium- and stannous fluoride, aminefluorides, sodium monofluorophosphate, sodium trimeta phosphate and casein;
plaque buffers such as urea, calcium lactate, calcium glycerophosphate and strontium polyacrylates;
vitamins such as Vitamins A, C and E;
plant extracts;
desensitising agents, e.g. potassium citrate, potassium chloride, potassium tartrate, potassium bicarbonate, potassium oxalate, potassium nitrate and strontium salts;
anti-calculus agents, e.g. alkali-metal pyrophosphates, hypophosphite-containing polymers, organic phosphonates and phosphocitrates etc.;
biomolecules, e.g. bacteriocins, antibodies, enzymes, etc.;
flavours, e.g. peppermint and spearmint oils;
proteinaceous materials such as collagen;
preservatives ;
opacifying agents;
colouring agents;
pH-adjusting agents;
sweetening agents;
pharmaceutically acceptable carriers, e.g. starch, sucrose, water or water/alcohol systems etc.;
surfactants, such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants;
particulate abrasive materials such as silicas, aluminas, calcium carbonates, dicalciumphosphates, calcium pyrophosphates, hydroxyapatites, trimetaphosphates, insoluble hexametaphosphates and so on, including agglomerated particulate abrasive materials, usually in amounts between 3 and 60% by weight of the oral care composition.
humectants such as glycerol, sorbitol, propyleneglycol, xylitol, lactitol etc.;
binders and thickeners such as sodium carboxymethyl- cellulose, xanthan gum, gum arabic etc. as well as synthetic polymers such as polyacrylates and carboxyvinyl polymers such as Carbopol®;
polymeric compounds which can enhance the delivery of active ingredients such as antimicrobial agents can also be included;
buffers and salts to buffer the pH and ionic strength of the oral care composition; and
other optional ingredients that may be included are e.g. bleaching agents such as peroxy compounds e.g. potassium peroxydiphosphate, effervescing systems such as sodium bicarbonate/citric acid systems, colour change systems, and so on.
Liposomes may also be used to improve delivery or stability of active ingredients.
The oral compositions may be in any form common in the art, e.g. toothpaste, gel, mousse, aerosol, gum, lozenge, powder, cream, etc. and may also be formulated into systems for use in dual-compartment type dispensers.
The oral composition according to the invention is made by standard protocols known to the person skilled in the art.
EXAMPLE
The following experiment illustrates the surprising effect of cerium oxide and lanthanum oxide in combination with abrasive silica.
The RDA is measured according to the protocol described in A Labora tory Method for Assessment of Dentifrice Abrasivity JJ Hefferren Journal Dent Res Vol 55 No 4 563-573 (1976) .
The PCR is measured according to the protocol described in In vi tro removal of stain with dentifrices GK Stookey, TA Burkhard and BR Schemehorn Journal Dent Res Vol 61 No 11 1236-1239 (1982) .
Both the cerium oxide and lanthanum oxide are commercially available from Aldrich.
Cerium (IV) oxide powder, cat no: 21,157-5.
Lanthanum oxide, cat no: 19,992-3.
Accordingly, it is evident that the addition of either of cerium oxide or lanthanum oxide to a standard toothpaste comprising abrasive silica results in an improved PCR without the expected increase in RDA.
Claims
1. Oral composition comprising as abrasive a mixture of a lanthanide metal oxide and a further abrasive, characterised in that the lanthanide metal oxide has a weight average particle size of from 0.5 to 50μm.
2. Oral composition according to claim 1 , wherein the further abrasive is selected from silica, calcium carbonate and mixtures thereof.
3. Oral composition according to any preceding claim, wherein the lanthanide' metal oxide is lanthanum oxide or cerium oxide.
4. Oral composition according to any preceding claim, wherein the lanthahide metal oxide has a weight average particle size of from 0.6 to 10μm.
5. Oral composition according to any preceding claim, wherein the further abrasive is calcium carbonate and is present at from 10 to 60% by weight of the composition.
6. Oral composition according to any of claims 1 to 4, wherein the further abrasive is silica and is present at from 3 to 15% by weight.
7. Use of from 0.01 to 5% by weight lanthanide metal oxide as an abrasive in an oral composition.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/551,012 US20070065375A1 (en) | 2003-04-02 | 2004-03-24 | Oral composition comprising micron-sized lanthanide metal oxide |
| BRPI0409535-9A BRPI0409535A (en) | 2003-04-02 | 2004-03-24 | oral composition and use of lanthanide metal oxide |
| EP04722867A EP1608328A1 (en) | 2003-04-02 | 2004-03-24 | Oral composition comprising micron-sized lanthanide metal oxide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03252083 | 2003-04-02 | ||
| EP03252083.5 | 2003-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004087088A1 true WO2004087088A1 (en) | 2004-10-14 |
Family
ID=33104183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2004/003234 WO2004087088A1 (en) | 2003-04-02 | 2004-03-24 | Oral composition comprising micron-sized lanthanide metal oxide |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070065375A1 (en) |
| EP (1) | EP1608328A1 (en) |
| CN (1) | CN1767801A (en) |
| BR (1) | BRPI0409535A (en) |
| CL (1) | CL2004000729A1 (en) |
| RU (1) | RU2005133703A (en) |
| WO (1) | WO2004087088A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102642859A (en) * | 2012-05-10 | 2012-08-22 | 建德市龙华塑化有限公司 | Production method of toothpaste-grade heavy calcium carbonate |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3573886A (en) * | 1968-08-19 | 1971-04-06 | Kerr Mc Gee Chem Corp | Rare-earth oxide and wollastonite polishing composition |
| DE2602981A1 (en) * | 1976-01-27 | 1977-07-28 | Carter Wallace | Dental prophylactic compsn. - contg. polyphosphate(s) and polyvalent cation |
| GB2001849A (en) * | 1977-06-23 | 1979-02-14 | Ici Ltd | Compositions for use in cleaning teeth containing at least one of yttrium scandium or lanthanum and the lanthanides |
| DE2802489A1 (en) * | 1978-01-20 | 1979-07-26 | Bayer Ag | Treating dental ivory esp. dentine lesions - using aq. or organic soln. of mineral and/or organic cerium salts |
| WO1995033441A1 (en) * | 1994-06-06 | 1995-12-14 | Block Drug Company, Inc. | Relief of dentinal hypersensitivity by submicron particles |
| US20010007161A1 (en) * | 1995-02-01 | 2001-07-12 | Gillette Canada Company, Reel | Tooth polishing brush |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4199563A (en) * | 1977-05-10 | 1980-04-22 | Bayer Aktiengesellschaft | Dental treatment agents and their medicinal use |
| US6258342B1 (en) * | 1999-11-03 | 2001-07-10 | Hercules Incorporated | Process for making toothpaste using agglomerated dispersible polymers |
| ATE462774T1 (en) * | 2000-10-16 | 2010-04-15 | 3M Innovative Properties Co | METHOD FOR PRODUCING CERAMIC AGGLOMERA PARTICLES |
-
2004
- 2004-03-24 BR BRPI0409535-9A patent/BRPI0409535A/en not_active IP Right Cessation
- 2004-03-24 WO PCT/EP2004/003234 patent/WO2004087088A1/en not_active Application Discontinuation
- 2004-03-24 CN CN200480008963.0A patent/CN1767801A/en active Pending
- 2004-03-24 RU RU2005133703/15A patent/RU2005133703A/en not_active Application Discontinuation
- 2004-03-24 US US10/551,012 patent/US20070065375A1/en not_active Abandoned
- 2004-03-24 EP EP04722867A patent/EP1608328A1/en not_active Withdrawn
- 2004-04-02 CL CL200400729A patent/CL2004000729A1/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3573886A (en) * | 1968-08-19 | 1971-04-06 | Kerr Mc Gee Chem Corp | Rare-earth oxide and wollastonite polishing composition |
| DE2602981A1 (en) * | 1976-01-27 | 1977-07-28 | Carter Wallace | Dental prophylactic compsn. - contg. polyphosphate(s) and polyvalent cation |
| GB2001849A (en) * | 1977-06-23 | 1979-02-14 | Ici Ltd | Compositions for use in cleaning teeth containing at least one of yttrium scandium or lanthanum and the lanthanides |
| DE2802489A1 (en) * | 1978-01-20 | 1979-07-26 | Bayer Ag | Treating dental ivory esp. dentine lesions - using aq. or organic soln. of mineral and/or organic cerium salts |
| WO1995033441A1 (en) * | 1994-06-06 | 1995-12-14 | Block Drug Company, Inc. | Relief of dentinal hypersensitivity by submicron particles |
| US20010007161A1 (en) * | 1995-02-01 | 2001-07-12 | Gillette Canada Company, Reel | Tooth polishing brush |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070065375A1 (en) | 2007-03-22 |
| BRPI0409535A (en) | 2006-04-18 |
| CL2004000729A1 (en) | 2005-05-27 |
| CN1767801A (en) | 2006-05-03 |
| RU2005133703A (en) | 2006-03-27 |
| EP1608328A1 (en) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1773279B1 (en) | Toothpaste comprising calcium carbonate and zinc citrate | |
| EP0740932B1 (en) | Clear gel-type dentifrices | |
| EP1843741B1 (en) | Opaque toothpaste composition | |
| WO1997002802A1 (en) | Self-heating dentifrice | |
| WO1999032074A2 (en) | Oral care composition | |
| EP1107725B1 (en) | Toothpaste comprising fine and coarse calcium carbonate | |
| JP2002521416A (en) | Anti-inflammatory dental care preparation | |
| EP2349187B1 (en) | Oral care composition | |
| EP1341513A1 (en) | Oral bleaching composition | |
| WO2008006725A1 (en) | Toothpaste composition | |
| WO2006012977A1 (en) | Composition | |
| WO2006050777A1 (en) | Toothpaste composition | |
| EP1263401B1 (en) | Oral composition comprising 2'-hydroxypropiophenone | |
| US20070065375A1 (en) | Oral composition comprising micron-sized lanthanide metal oxide | |
| US20030068283A1 (en) | Composition | |
| US6436372B2 (en) | Oral composition with abrasive mixture of chalk and carbide | |
| EP1418882A1 (en) | Oral composition comprising an alkylhydroxybenzoate | |
| US20030068282A1 (en) | Composition | |
| WO2001001938A1 (en) | Oral composition comprising capsules | |
| EP3701932A1 (en) | Odour reducing compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2004722867 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1200501427 Country of ref document: VN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1058//MUMNP/2005 Country of ref document: IN Ref document number: 1058/MUMNP/2005 Country of ref document: IN Ref document number: 1-2005-501760 Country of ref document: PH Ref document number: 200507936 Country of ref document: ZA Ref document number: 20048089630 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005133703 Country of ref document: RU |
|
| WWP | Wipo information: published in national office |
Ref document number: 2004722867 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: PI0409535 Country of ref document: BR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007065375 Country of ref document: US Ref document number: 10551012 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 10551012 Country of ref document: US |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2004722867 Country of ref document: EP |